1-14 of 14
Hans C. Hasselbalch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Calr Mutations in Individuals of the Background Population Reveals Undiagnosed Myeloproliferative Neoplasms and Surprisingly Stable Low Levels of Calr Mutant Allele Burden in Individuals Not Developing Myeloproliferative Neoplasm during 10-14 Year Follow-up

Lasse Kjær, Morten Kranker Larsen, Vibe Skov, Trine Alma Knudsen, Sabrina Cordua Bech, Jordan A. Snyder, Johanne Gudmand-Høyer, Morten Andersen, Johnny T. Ottesen, Thomas Stiehl, Christina Ellervik, Hans C. Hasselbalch
Journal: Blood
Blood (2024) 144 (Supplement 1): 1806.
https://doi.org/10.1182/blood-2024-210127
Published: 2024
Journal Articles

Circulating Extracellular Matrix Fragments As Biomarkers in Myeloproliferative Neoplasms - Baseline Data from the Daliah Trial

Caroline Norup Bistrup, Morten Kranker Larsen, Peter Junker, Vibe Skov, Lasse Kjær, Trine Alma Knudsen, Morten Karsdal, Nicholas Willumsen, Hans C. Hasselbalch
Journal: Blood
Blood (2024) 144 (Supplement 1): 4545.
https://doi.org/10.1182/blood-2024-200727
Published: 2024
Journal Articles

Statins Enhance the Efficacy of Pegylated Interferon-alpha2 in Patients with Ph-Negative Chronic Myeloproliferative Neoplasms. Results from a Danish Single-Institution Cohort Study

Isabella Diana Hansen, Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Ellervik, Anders Lindholm Sørensen, Trine Alma Knudsen, Sarah Friis Christensen, Sabrina Cordua, Christina Schjellerup Eickhardt-Dalbøge, Troels Wienecke, Marie Hvelplund Kristiansen, Hans C. Hasselbalch
Journal: Blood
Blood (2024) 144 (Supplement 1): 3184.
https://doi.org/10.1182/blood-2024-203051
Published: 2024
Journal Articles

Final Analysis of the Daliah Trial: A Randomized Phase III Trial of Interferon-α Versus Hydroxyurea in Patients with MPN

Trine Alma Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Bjerrum, Mette Brabrand, Sarah Friis Christensen, Christina Schjellerup Eickhardt-Dalbøge, Christina Ellervik, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben A. Kruse, Morten Kranker Larsen, Torben Mourits-Andersen, Sören Möller, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Anders Lindholm Sørensen, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas S. Larsen, Hans C. Hasselbalch
Journal: Blood
Blood (2023) 142 (Supplement 1): 746.
https://doi.org/10.1182/blood-2023-173127
Published: 2023
Journal Articles

The Gut Microbiota in Patients with Polycythemia Vera: Novel Vs. Conventional Treatments

Christina Schjellerup Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, Henrik V Nielsen, Kurt Fuursted, Morten Kranker Larsen, Lasse Kjær, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Hans C. Hasselbalch, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen
Journal: Blood
Blood (2021) 138 (Supplement 1): 1501.
https://doi.org/10.1182/blood-2021-148350
Published: 2021
Journal Articles

The Impact of Somatic Mutations upon the Response to Combination Therapy with Ruxolitinib and Interferon in MPN Patients

Vibe Skov, Anders Lindholm Sørensen, Trine Alma Knudsen, Mads Emil Bjørn, Christina Ellervik, Morten Kranker Larsen, Christina Schjellerup Schjellerup Eickhardt-Dalbøge, Sarah Friis Christensen, Mads Thomassen, Torben A Kruse, Hans C. Hasselbalch
Journal: Blood
Blood (2021) 138 (Supplement 1): 3589.
https://doi.org/10.1182/blood-2021-152154
Published: 2021
Journal Articles

Labor Market Attachment in Patients with Myeloproliferative Neoplasms: A Nationwide Matched Cohort Study

Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjærsgaard, Anna Stenling, Björn Paulsson, Christen Lykkegaard Andersen, Christian Fynbo Christiansen, Jesper Stentoft, Jørn Starklint, Marianne Tang Severinsen, Mette Borg Clausen, Morten Hagemann Hilsøe, Henrik Frederiksen, Hans C. Hasselbalch, Marie Bak, Ellen Margrethe Mikkelsen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3627.
https://doi.org/10.1182/blood-2021-144587
Published: 2021
Journal Articles

Polycythemia Vera Patients Respond Better to Ropeginterferon Alfa-2b Than HU/BAT Irrespective of Pretreatment or Mutational Status; Results from 5 Years' Treatment in a Randomized, Controlled Setting in the PROUD-PV/Continuation-PV Trials

Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian
Journal: Blood
Blood (2021) 138 (Supplement 1): 3660.
https://doi.org/10.1182/blood-2021-152328
Published: 2021
Journal Articles

Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: 5-Year Results from a Randomized Controlled Study and Its Extension

Heinz Gisslinger, MD, Christoph Klade, PhD, Pencho Georgiev, MD, Dorota Krochmalczyk, MD, Liana Gercheva-Kyuchukova, MD, Miklos Egyed, MD, Petr Dulicek, MD, Árpád Illés, MD PhD, Halyna Pylypenko, MD, Lylia Sivcheva, MD, Jiří Mayer, Vera Yablokova, MD, Kurt Krejcy, MD, Victoria Empson, MSc, Hans C. Hasselbalch, MD, Robert Kralovics, PhD, Jean Jacques Kiladjian, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33.
https://doi.org/10.1182/blood-2020-136973
Published: 2020
Journal Articles

Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population

Sabrina Cordua, Lasse Kjaer, Vibe Skov, Niels Pallisgaard, Hans C. Hasselbalch, Christina Ellervik
Journal: Blood
Blood (2019) 134 (5): 469–479.
https://doi.org/10.1182/blood.2019001113
Published: 2019
Includes: Supplemental data
Journal Articles

FLT3-Mediated MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis.

Christophe Desterke, Chrystele Bilhou-Nabera, MD, PhD, Bernadette Guerton, Carole Tonetti, Denis Clay, Olivier Pierre-Louis, Alessandro M Vannucchi, MD, PhD, Heinz Gisslinger, MD, PhD, Dominique Bordessoule, MD, PhD, Hans C Hasselbalch, MD, PhD, Vladimir Lazar, PhD, William Vainchenker, MD, PhD, Annelise Bennaceur-Griscelli, MD, PhD, Stéphane Giraudier, MD, PhD, Marie-Caroline Le Bousse-Kerdilès, PhD
Journal: Blood
Blood (2009) 114 (22): 963.
https://doi.org/10.1182/blood.V114.22.963.963
Published: 2009
Journal Articles

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip A. Beer, Peter J. Campbell, Linda M. Scott, Anthony J. Bench, Wendy N. Erber, David Bareford, Bridget S. Wilkins, John T. Reilly, Hans C. Hasselbalch, Richard Bowman, Keith Wheatley, Georgina Buck, Claire N. Harrison, Anthony R. Green
Journal: Blood
Blood (2008) 112 (1): 141–149.
https://doi.org/10.1182/blood-2008-01-131664
Published: 2008
Includes: Supplemental data
Journal Articles

Quantitative PCR Assessment of JAK2 Mutational Status in Philadelphia-Chromosome Negative Chronic Myeloproliferative Disorders - The JAK2 V617F Mutation Is an Event in an Early Stem Cell and the Clonal Involvement of Different Haematopoietic Cells Varies between Individual Patients.

Thomas S. Larsen, MD, Hans C. Hasselbalch, M.D DMsc, Niels Pallisgaard
Journal: Blood
Blood (2006) 108 (11): 3602.
https://doi.org/10.1182/blood.V108.11.3602.3602
Published: 2006
Journal Articles

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis

Clinical Trials & Observations
Peter J. Campbell, Martin Griesshammer, Konstanze Döhner, Hartmut Döhner, Rajko Kusec, Hans C. Hasselbalch, Thomas Stauffer Larsen, Niels Pallisgaard, Stéphane Giraudier, Marie-Caroline Le Bousse-Kerdilès, Christophe Desterke, Bernadette Guerton, Brigitte Dupriez, Dominique Bordessoule, Pierre Fenaux, Jean-Jacques Kiladjian, Jean-François Viallard, Jean Brière, Claire N. Harrison, Anthony R. Green, John T. Reilly
Journal: Blood
Blood (2006) 107 (5): 2098–2100.
https://doi.org/10.1182/blood-2005-08-3395
Published: 2006